Electroceuticals are medical devices that affect changes in body functions by utilizing electrical impulses. Electroceuticals act as an alternative to drug-based remedies, and are expected to be the future gold standard of treatment of various diseases. Unlike other stimulators of the muscles or tissues, electroceuticals act on the basis of neurostimulation, which is the modulation of the nervous systems using electrical impulses. Current treatment options in several neurological disorders and other disease states depend upon drug-based medications, which are associated with considerable side effects and promises of delivery of results are not yet totally fulfilled. Electroceuticals have found applications in various diseases and disorders and are effective in treatment of these conditions in both invasive and non-invasive methods. These are considered a genuine replacement of drug-based medications in future.
The global electroceuticals/bioelectric medicine market is segmented based on product, device type, end-user, application, and region. In terms of product, the global electroceuticals/bioelectric medicine market is segmented into cardiac pacemakers, deep brain stimulators, implantable cardioverter defibrillators, cochlear implants, spinal cord stimulators, vagus nerve stimulators, and others. The implantable cardioverter defibrillators segment accounted for the largest share of the global electroceuticals/bioelectric medicine market. Based on end-user, the global electroceuticals/bioelectric medicine market is segmented into hospitals, clinics, home care settings, and others. In terms of device type, the global electroceuticals/bioelectric medicine market is segmented into non-invasive electroceuticals and implantable electroceuticals. The implantable electroceuticals segment is expected to account for the largest share of the market. However, the non-invasive electroceuticals segment is projected to expand at a higher CAGR during the forecast period. Based on application, the global electroceuticals/bioelectric medicine market is segmented into arrhythmias, epilepsy, Parkinson’s disease, spinal cord disorders, and other applications.
Request a PDF Brochure with Report Analysis:
Increasing global geriatric population, rising cost pressures of drug based medicines, growing interest from major pharmaceutical players in the electroceuticals segment, and increasing incidence and prevalence of neurological disorders and chronic diseases across the world are some of the factors likely to boost the growth of the global electroceuticals market during the forecast period. Major players such as GlaxoSmithKline plc have made significant investments in the electroceuticals segment and other organizations such as the National Institutes of Health (NIH) in the U.S. have shown great interest in the field of electroceuticals. Increasing incidence of neurological disorders such as epilepsy, Parkinson’s diseases, and other chronic diseases are expected to augment the electroceuticals/bioelectric medicine market during the forecast period from 2016 to 2024.
In terms of region, the global electroceuticals/biomedicine market is segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in Asia Pacific is expected to expand at the fastest CAGR during the forecast period due to higher prevalence of chronic diseases such as diabetes and hearing loss due to rapidly increasing geriatric population in China, Japan, and India, increasing incidence of neurological disorders, and rising adoption of neurostimulation techniques. North America dominated the global electroceuticals/bioelectric medicine market in 2015 owing to factors such as increasing adoption of neurostimulation techniques, new and technologically advanced products being introduced, rising awareness about electroceuticals/bioelectric medicine, and increasing neurological and chronic diseases.
Key players in the electroceuticals/bioelectric medicine market are Boston Scientific Corporation, Cochlear Limited, Medtronic plc, St. Jude Medical, Inc., Biotronik, Sonova Holding AG, LivaNova plc, ElectroCore LLC, Nevro Corporation, and Second Sight Medical Products, Inc. Other pharmaceutical companies such as GlaxoSmithKline plc have invested in the electroceuticals market, with increased focus on bringing new miniaturized electroceutical devices in the market.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Browse Full Research Report on Electroceuticals/Bioelectric Medicine Market:
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR Syndicated Research report covers a different sector - such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
Browse market research blog: